Article
Dapagliflozin protects heart function against type-4 cardiorenal syndrome through activation of PKM2/PP1/FUNDC1-dependent mitophagy
2 Aug 2023
Abstract excerpt
No abstract is available from the source.
Topics
Join the communities discussing this publication.
